Andrew N Hanna

5PUBLICATIONS
14CO-AUTHORS
Biomedical imagingTumour immunologyCancer geneticsGeospatial information systems and geospatial data modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 27, 2023
Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in PDGFRA D842V-Mutant Gastrointestinal Stromal Tumor.

Ferdinand Rossi, Mengyuan Liu, Andrew Tieniber

|Aug 02, 2022
Tyrosine Kinase Inhibition Alters Intratumoral CD8+ T-cell Subtype Composition and Activity.

Andrew D Tieniber, Andrew N Hanna, Benjamin D Medina

|Jun 18, 2021
ASO Author Reflections: How Important is Type in the Management of Gastric Neuroendocrine Tumors?

Andrew Hanna, Robert E Roses

|Jun 13, 2021
Gastric Neuroendocrine Tumors: Reappraisal of Type in Predicting Outcome.

Andrew Hanna, Caroline Kim-Kiselak, Rebecca Tang

|Mar 02, 2021
Oncogenic KIT Modulates Type I IFN-Mediated Antitumor Immunity in GIST.

Mengyuan Liu, Mark S Etherington, Andrew Hanna

Pageof 1